A new effector of lipid metabolism: Complement factor properdin

Molecular Immunology

Volumn 51, Issue 1, 2012, Pages 73-81

  Gauvreau, Danny ^a,b   Roy, Christian ^a,b   Tom, Fun Qun ^a,b   Lu, HuiLing ^a,b   Miegueu, Pierre ^a,b   Richard, Denis ^a,b   Song, Wen Chao ^c   Stover, Cordula ^d   Cianflone, Katherine ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Acylation stimulating protein; Alternative complement pathway; Properdin; Triglyceride

Indexed keywords

ADIPONECTIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR D; COMPLEMENT FACTOR H; LEPTIN; PROPERDIN; RESISTIN; SOMATOMEDIN BINDING PROTEIN 5;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; ENERGY EXPENDITURE; ENERGY METABOLISM; FAT MASS; FATTY ACID TRANSPORT; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; IN VITRO STUDY; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; MOUSE; MUSCLE CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SKELETAL MUSCLE; WEIGHT GAIN;

3T3 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CELL LINE; COMPLEMENT ACTIVATION; ENERGY METABOLISM; FATTY ACIDS; FEMALE; GLUCOSE; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE CELLS; PROPERDIN; RATS;

MURINAE; MUS; RATTUS;

EID: 84859624552     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.02.110     Document Type: Article

References (51)

1. Bedard S., Marcotte B., Marette A. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem. J. 1997, 325(Pt 2):487-493.
2. Choy L.N., Rosen B.S., Spiegelman B.M. Adipsin and an endogenous pathway of complement from adipose cells. J. Biol. Chem. 1992, 267:12736-12741.
3. Cui W., Lapointe M., Gauvreau D., Kalant D., Cianflone K. Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation. Mol. Immunol. 2009, 46:3207-3217.
4. Cui W., Paglialunga S., Kalant D., Lu H., Roy C., Laplante M., Deshaies Y., Cianflone K. Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1482-E1491.
5. Cui W., Simaan M., Laporte S., Lodge R., Cianflone K. C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation. Mol. Immunol. 2009, 46:3086-3098.
6. Dallinga-Thie G.M., Franssen R., Mooij H.L., Visser M.E., Hassing H.C., Peelman F., Kastelein J.J., Peterfy M., Nieuwdorp M. The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis 2010, 211:1-8.
7. Densupsoontorn N., Carpentier Y.A., Racine R., Murray F.M., Seo T., Ramakrishnan R., Deckelbaum R.J. CD36 and proteoglycan-mediated pathways for (n-3) fatty acid enriched triglyceride-rich particle blood clearance in mouse models in vivo and in peritoneal macrophages in vitro. J. Nutr. 2008, 138:257-261.
8. Dimitrova P., Ivanovska N., Schwaeble W., Gyurkovska V., Stover C. The role of properdin in murine zymosan-induced arthritis. Mol. Immunol. 2010, 47:1458-1466.
9. Ehrnthaller C., Ignatius A., Gebhard F., Huber-Lang M. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol. Med. 2011, 17:317-329.
10. Fujita T., Fujioka T., Murakami T., Satomura A., Fuke Y., Matsumoto K. Chylomicron accelerates C3 tick-over by regulating the role of factor H, leading to overproduction of acylation stimulating protein. J. Clin. Lab. Anal. 2007, 21:14-23.
11. Gao Y., Gauvreau D., Cianflone K. Hormone and pharmaceutical regulation of ASP production in 3T3-L1 adipocytes. J. Cell. Biochem. 2010, 109:896-905.
12. Gray P., Dagvadorj J., Michelsen K.S., Brikos C., Rentsendorj A., Town T., Crother T.R., Arditi M. Myeloid differentiation factor-2 interacts with Lyn kinase and is tyrosine phosphorylated following lipopolysaccharide-induced activation of the TLR4 signaling pathway. J. Immunol. 2011, 187:4331-4337.
13. Higgins J.M., Wiedemann H., Timpl R., Reid K.B. Characterization of mutant forms of recombinant human properdin lacking single thrombospondin type I repeats. Identification of modules important for function. J. Immunol. 1995, 155:5777-5785.
14. Huber-Lang M., Younkin E.M., Sarma J.V., Riedemann N., McGuire S.R., Lu K.T., Kunkel R., Younger J.G., Zetoune F.S., Ward P.A. Generation of C5a by phagocytic cells. Am. J. Pathol. 2002, 161:1849-1859.
15. Hussain M.M., Maxfield F.R., Mas-Oliva J., Tabas I., Ji Z.S., Innerarity T.L., Mahley R.W. Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J. Biol. Chem. 1991, 266:13936-13940.
16. Kemper C., Atkinson J.P., Hourcade D.E. Properdin: emerging roles of a pattern-recognition molecule. Annu. Rev. Immunol. 2010, 28:131-155.
17. Kemper C., Hourcade D.E. Properdin: new roles in pattern recognition and target clearance. Mol. Immunol. 2008, 45:4048-4056.
18. Kimura Y., Miwa T., Zhou L., Song W.C. Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 2008, 111:732-740.
19. Lehr S., Hartwig S., Lamers D., Famulla S., Mueller S., Hanisch F.G., Cuvelier C., Ruige J., Eckardt K., Ouwens D.M., Sell H., Eckel J. Identification and validation of novel adipokines released from primary human adipocytes. Mol. Cell Proteomics 2011, [Epub ahead of print].
20. Lewis R.D., Perry M.J., Guschina I.A., Jackson C.L., Morgan B.P., Hughes T.R. CD55 deficiency protects against atherosclerosis in ApoE-deficient mice via C3a modulation of lipid metabolism. Am. J. Pathol. 2011, 179:1601-1607.
21. Mamane Y., Chung C.C., Lavallee G., Morin N., Xu L.J., Huang J., Gordon R., Thomas W., Lamb J., Schadt E.E., Kennedy B.P., Mancini J.A. The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation. Diabetes 2009, 58:2006-2017.
22. Maslowska M., Scantlebury T., Germinario R., Cianflone K. Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. J. Lipid Res. 1997, 38:1-11.
23. Maslowska M., Legakis H., Assadi F., Cianflone K. Targeting the signaling pathway of acylation stimulating protein. J. Lipid Res. 2006, 47:643-652.
24. Maslowska M., Sniderman A.D., Germinario R., Cianflone K. ASP stimulates glucose transport in cultured human adipocytes. Int. J. Obes. Relat. Metab. Disord. 1997, 21:261-266.
25. Maslowska M.H., Sniderman A.D., MacLean L.D., Cianflone K. Regional differences in triacylglycerol synthesis in adipose tissue and in cultured preadipocytes. J. Lipid Res. 1993, 34:219-228.
26. McLean R.H., Hoefnagel D. Partial lipodystrophy and familial C3 deficiency. Hum. Hered. 1980, 30:149-154.
27. Meilinger M., Gschwentner C., Burger I., Haumer M., Wahrmann M., Szollar L., Nimpf J., Huettinger M. Metabolism of activated complement component C3 is mediated by the low density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor. J. Biol. Chem. 1999, 274:38091-38096.
28. Miegueu P., Cianflone K., Richard D., St-Pierre D.H. Motilin stimulates preadipocyte proliferation and differentiation and adipocyte lipid storage. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E758-E766.
29. Misra A., Peethambaram A., Garg A. Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore) 2004, 83:18-34.
30. Nolan K.F., Schwaeble W., Kaluz S., Dierich M.P., Reid K.B. Molecular cloning of the cDNA coding for properdin, a positive regulator of the alternative pathway of human complement. Eur. J. Immunol. 1991, 21:771-776.
31. Paglialunga S., Fisette A., Yan Y., Deshaies Y., Brouillette J.F., Pekna M., Cianflone K. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E521-E529.
32. Pattrick M., Luckett J., Yue L., Stover C. Dual role of complement in adipose tissue. Mol. Immunol. 2009, 46:755-760.
33. Peake P., Shen Y. Factor H binds to the N-terminus of adiponectin and modulates complement activation. Biochem. Biophys. Res. Commun. 2010, 397:361-366.
34. Peake P.W., O'Grady S., Pussell B.A., Charlesworth J.A. Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes. Eur. J. Clin. Invest. 1997, 27:922-927.
35. Peake P.W., Shen Y., Walther A., Charlesworth J.A. Adiponectin binds C1q and activates the classical pathway of complement. Biochem. Biophys. Res. Commun. 2008, 367:560-565.
36. Roy C., Paglialunga S., Fisette A., Schrauwen P., Moonen-Kornips E., St Onge J., Hesselink M.K., Richard D., Joanisse D.R., Cianflone K. Shift in metabolic fuel in acylation-stimulating protein-deficient mice following a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E1051-E1059.
37. Savage D.B., Semple R.K., Clatworthy M.R., Lyons P.A., Morgan B.P., Cochran E.K., Gorden P., Raymond-Barker P., Murgatroyd P.R., Adams C., Scobie I., Mufti G.J., Alexander G.J., Thiru S., Murano I., Cinti S., Chaudhry A.N., Smith K.G., O'Rahilly S. Complement abnormalities in acquired lipodystrophy revisited. J. Clin. Endocrinol. Metab. 2009, 94:10-16.
38. Scantlebury T., Maslowska M., Cianflone K. Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. J. Biol. Chem. 1998, 273:20903-20909.
39. Schaffler A., Scholmerich J. Innate immunity and adipose tissue biology. Trends Immunol. 2010, 31:228-235.
40. Silverstein R.L., Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal. 2009, 2:re3.
41. Singer L., Colten H.R., Wetsel R.A. Complement C3 deficiency: human, animal, and experimental models. Pathobiology 1994, 62:14-28.
42. Sissons J.G., West R.J., Fallows J., Williams D.G., Boucher B.J., Amos N., Peters D.K. The complement abnormalities of lipodystrophy. N. Engl. J. Med. 1976, 294:461-465.
43. Smith K.F., Nolan K.F., Reid K.B., Perkins S.J. Neutron and X-ray scattering studies on the human complement protein properdin provide an analysis of the thrombospondin repeat. Biochemistry 1991, 30:8000-8008.
44. Smith C.A., Pangburn M.K., Vogel C.W., Muller-Eberhard H.J. Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement. J. Biol. Chem. 1984, 259:4582-4588.
45. Spitzer D., Mitchell L.M., Atkinson J.P., Hourcade D.E. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J. Immunol. 2007, 179:2600-2608.
46. Stover C.M., Luckett J.C., Echtenacher B., Dupont A., Figgitt S.E., Brown J., Mannel D.N., Schwaeble W.J. Properdin plays a protective role in polymicrobial septic peritonitis. J. Immunol. 2008, 180:3313-3318.
47. Tao Y., Cianflone K., Sniderman A.D., Colby-Germinario S.P., Germinario R.J. Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. Biochim. Biophys Acta 1997, 1344:221-229.
48. van Greevenbroek M.M. The expanding role of complement in adipose tissue metabolism and lipoprotein function. Curr. Opin. Lipidol. 2009, 20:353-354.
49. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
50. Wang Y., Van Oort M.M., Yao M., Van der Horst D.J., Rodenburg K.W. Insulin and chromium picolinate induce translocation of CD36 to the plasma membrane through different signaling pathways in 3T3-L1 adipocytes, and with a differential functionality of the CD36. Biol. Trace Elem. Res. 2011, 142:735-747.
51. Zhang J., Wright W., Bernlohr D.A., Cushman S.W., Chen X. Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E1433-E1440.